Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133. (2018)

Peer-Reviewed Study · Sinha AA, Wilson MJ · October 2018

Sinha AA et al., 2018-10: Human prostate biopsy and prostatectomy sections from 13 untreated and 8 diethylstilbestrol-treated men were methylene blue-stained to identify two CD133-positive stem-cell populations. Methylene blue is used here as a histological stain, not as a treatment.

Methylene blue stained basic proteins in dark basal cells, but not in light cells.

Sinha AA et al., 2018-10: Human prostate biopsy and prostatectomy sections from 13 untreated and 8 diethylstilbestrol-treated men were methylene blue-stained to identify two CD133-positive stem-cell populations. Methylene blue is used here as a histological stain, not as a treatment. C1. Study type: human tissue histology (observational laboratory study). N: 21 men (13 untreated, 8 DES-treated). Country: USA (Minneapolis VA Healthcare System; University of Minnesota). Dose/route: methylene blue as an Epon-section stain; concentration and protocol not in the abstract. Funder: no grant listed. Conflicts: none declared in the record. Comparator: untreated vs DES-treated tissue; paraffin vs Epon embedding. Bears on C1 only as evidence that MB is used on human prostate cancer tissue; it tests no anticancer effect. Study type: lab.